시장보고서
상품코드
1951840

가치 기반 헬스케어 서비스 시장 분석과 예측 : 유형별, 제품 유형별, 서비스별, 기술별, 구성 요소별, 용도별, 최종 사용자별, 도입 형태별, 기능별(-2035년)

Value-Based Healthcare Services Market Analysis and Forecast to 2035: Type, Product, Services, Technology, Component, Application, End User, Deployment, Functionality

발행일: | 리서치사: Global Insight Services | 페이지 정보: 영문 354 Pages | 배송안내 : 3-5일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

가치 기반 헬스케어 서비스 시장은 2024년 33억 달러로 평가되었고, 2034년까지 67억 달러에 이르고, CAGR은 약 6.3%를 나타낼 것으로 예측됩니다. 가치 기반 헬스케어 서비스 시장은 서비스량보다 환자의 치료 성과를 우선하고 질과 효율성을 평가하는 지불 모델을 통합하는 변혁적인 접근법을 포함하고 있습니다. 이 패러다임 이동은 의료 제공업체의 책임을 촉진하고 환자의 만족도를 높이고 비용을 절감합니다. 정책 개혁과 기술 진보에 견인되어 본 시장은 데이터 분석, 케어 조정, 맞춤형 치료를 중시하고 있습니다. 전 세계적으로 의료 시스템이 가치 기반 케어로 이행하는 중, 환자와의 관계, 만성 질환 관리, 통합형 헬스 솔루션에 있어서의 혁신의 기회가 풍부하게 존재합니다.

가치 기반 헬스케어 서비스 시장은 환자 중심의 케어와 성과에 기초한 보상 모델로의 이행을 원동력으로 견고한 성장을 이루고 있습니다. 서비스 분야가 가장 높은 성장률을 나타내고 만성 질환 관리 서비스와 케어 조정 서비스가 견인 역할을 하고 있습니다. 이러한 서비스는 환자 결과 개선 및 의료비 절감에 필수적입니다. 데이터 분석 및 원격 의료 솔루션을 포함한 기술 분야도 이에 이어 의료 제공의 질 향상을 위한 디지털 툴의 통합이 진행되고 있습니다. 집단 건강 관리는 의료 제공업체가 환자 집단을 보다 효과적으로 관리할 수 있도록 하기 위해 큰 관심을 받고 있습니다. 환자 참여 솔루션에 대한 수요는 환자와 의료 제공업체 간의 의사 소통 개선 및 치료 계획 준수의 필요성으로 인해 증가하고 있습니다. 예방 의료 서비스는 조기 개입과 건강 증진을 중시하는 주요 초점 영역으로 부상하고 있습니다. 의료 IT 인프라의 진보와 가치를 바탕으로 한 의료 이니셔티브에 대한 중점 강화가 시장을 더욱 추진하고 이해 관계자에게 수익성이 높은 기회를 창출하고 있습니다.

시장 세분화
유형 통합 케어 모델, 책임 의료 기구(ACO), 환자 중심 의료 홈, 성과 기반 보상제(P4P), 묶음 지불 제도
제품 소프트웨어 솔루션, 분석 솔루션, 컨설팅 서비스
서비스 케어 매니지먼트 서비스, 환자 참여 솔루션, 리스크 관리 서비스
기술 원격 의료, 전자의무기록, 원격 모니터링, 모바일 헬스 용도
구성요소 하드웨어, 소프트웨어, 서비스
신청 만성 질환 관리, 인구 건강 관리, 재택치료 관리
최종 사용자 의료 제공업체, 지불자, 환자
도입 형태 On-Premise, 클라우드 기반, 하이브리드
기능 데이터 분석, 상호 운용성, 환자 참여

가치 기반 헬스케어 서비스 시장에서는 혁신과 전략적 제휴를 원동력으로 하여 시장 점유율과 가격 전략에 역동적인 변화가 발생하고 있습니다. 신제품의 투입이 업계의 양상을 일변시키고 있으며, 의료 제공업체는 환자 중심의 솔루션에 주력하고 있습니다. 이 변화는 환자의 치료 성과를 향상시키고 업무 효율을 최적화하는 첨단 기술의 통합에 의해 추진되고 있습니다. 시장은 경쟁적인 가격 환경이 특징이며, 제공업체에게 서비스의 혁신과 차별화를 촉구하고 있습니다. 가치 기반 헬스케어 서비스 시장에서의 경쟁은 치열해지고 있으며, 주요 기업은 경쟁 우위를 유지하기 위해 업계 리더를 벤치마킹 대상으로 하고 있습니다. 정부 정책과 상환 모델이 시장 역학을 좌우하는 중요한 요소이기 때문에 규제의 영향은 엄청납니다. 북미는 규제면에서 진전을 이끌어 성장에 적합한 환경을 조성하고 있습니다. 신흥경제국이 의료 인프라에 많은 투자를 하고 있기 때문에 시장은 확대의 기운에 있어 이해관계자에게 유리한 성장 기회를 제공합니다. 컴플라이언스 및 데이터 보안과 같은 과제는 여전히 존재하지만, 기술 발전은 상당한 성장 가능성을 약속합니다.

주요 동향과 촉진요인

가치 기반 헬스케어 서비스 시장은 환자 중심의 케어와 비용 효과에 중시가 높아지는 것을 배경으로 견고한 성장을 이루고 있습니다. 주요 동향으로는 디지털 건강 기술의 통합이 포함되어 환자의 참여를 촉진하고 케어 조정을 효율화하고 있습니다. 원격 의료 서비스와 원격 모니터링의 보급이 진행되어 환자의 편의성 향상과 비용 절감을 실현하고 있습니다. 또 다른 중요한 촉진요인은 성과 기반 보상제 모델로의 전환입니다. 이를 통해 의료 제공업체는 환자의 치료 성과 향상에 인센티브를 얻고 예방 의료 및 만성 질환 관리 프로그램의 도입을 촉진합니다. 또한, 만성 질환 증가와 노화 사회의 진전은 가치 기반 의료 솔루션 수요를 더욱 뒷받침하고 있습니다. 의료 시스템은 비용을 효과적으로 관리하면서 품질 향상에 주력하는 경향이 커지고 있습니다. 의료 인프라가 개발 도상에 있는 신흥 경제국에서는 풍부한 비즈니스 기회가 존재합니다. 확장 가능한 기술 주도형 솔루션을 제공하는 기업은 이러한 신흥 시장을 활용하는 데 유리한 입장에 있습니다. 또한 의료 제공업체, 보험자 및 기술 기업 간의 협력은 혁신을 촉진하고 가치 기반 의료에 대한 액세스를 확대하고 있습니다. 업계가 진화를 계속하고 있는 가운데, 개별화된 케어와 데이터에 근거한 의사결정에의 주력이 시장의 지속적인 성장을 견인해 나갈 것입니다.

목차

제1장 주요 요약

제2장 시장 하이라이트

제3장 시장 역학

  • 거시경제 분석
  • 시장 동향
  • 시장 성장 촉진요인
  • 시장 기회
  • 시장 성장 억제요인
  • CAGR : 성장 분석
  • 영향 분석
  • 신흥 시장
  • 기술 로드맵
  • 전략적 프레임워크

제4장 부문 분석

  • 시장 규모 및 예측 : 유형별
    • 통합 케어 모델
    • 책임 의료 기구
    • 환자 중심 의료 홈
    • 성과 기반 보상제
    • 묶음 지불 제도
  • 시장 규모 및 예측 : 제품별
    • 소프트웨어 솔루션
    • 분석 솔루션
    • 컨설팅 서비스
  • 시장 규모 및 예측 : 서비스별
    • 케어 관리 서비스
    • 환자 참여 솔루션
    • 리스크 관리 서비스
  • 시장 규모 및 예측 : 기술별
    • 원격 의료
    • 전자의무기록
    • 원격 모니터링
    • 모바일 헬스 용도
  • 시장 규모 및 예측 : 구성요소별
    • 하드웨어
    • 소프트웨어
    • 서비스
  • 시장 규모 및 예측 : 용도별
    • 만성 질환 관리
    • 인구 건강 관리
    • 재택 치료 관리
  • 시장 규모 및 예측 : 최종사용자별
    • 의료 제공업체
    • 지불자
    • 환자
  • 시장 규모 및 예측 : 전개별
    • On-Premise
    • 클라우드 기반
    • 하이브리드
  • 시장 규모 및 예측 : 기능별
    • 데이터 분석
    • 상호 운용성
    • 환자 참여

제5장 지역별 분석

  • 북미
    • 미국
    • 캐나다
    • 멕시코
  • 라틴아메리카
    • 브라질
    • 아르헨티나
    • 기타 라틴아메리카
  • 아시아태평양
    • 중국
    • 인도
    • 한국
    • 일본
    • 호주
    • 대만
    • 기타 아시아태평양
  • 유럽
    • 독일
    • 프랑스
    • 영국
    • 스페인
    • 이탈리아
    • 기타 유럽
  • 중동 및 아프리카
    • 사우디아라비아
    • 아랍에미리트(UAE)
    • 남아프리카
    • 사하라 이남 아프리카
    • 기타 중동 및 아프리카

제6장 시장 전략

  • 수요 및 공급 격차 분석
  • 무역 및 물류상의 제약
  • 가격-비용-마진 추세
  • 시장 침투
  • 소비자 분석
  • 규제 개요

제7장 경쟁 정보

  • 시장 포지셔닝
  • 시장 점유율
  • 경쟁 벤치마킹
  • 주요 기업의 전략

제8장 기업 프로파일

  • Evolent Health
  • Privia Health
  • Oak Street Health
  • Agilon Health
  • Village MD
  • Lumeris
  • Health Catalyst
  • Innovaccer
  • Signify Health
  • Care Centrix
  • Aledade
  • Clover Health
  • Bright Health
  • Cityblock Health
  • Somatus
  • Iora Health
  • Chen Med
  • Landmark Health
  • One Medical
  • Alignment Healthcare

제9장 당사에 대해서

SHW 26.03.13

Value-Based Healthcare Services Market is anticipated to expand from $3.3 billion in 2024 to $6.7 billion by 2034, growing at a CAGR of approximately 6.3%. The Value-Based Healthcare Services Market encompasses a transformative approach prioritizing patient outcomes over service volume, integrating payment models that reward quality and efficiency. This paradigm shift fosters provider accountability, enhances patient satisfaction, and reduces costs. Driven by policy reforms and technological advancements, the market emphasizes data analytics, care coordination, and personalized treatment. As healthcare systems globally transition towards value-based care, opportunities abound for innovation in patient engagement, chronic disease management, and integrated health solutions.

The Value-Based Healthcare Services Market is experiencing robust growth, driven by the shift towards patient-centric care and outcome-based reimbursement models. The services segment is the top performer, with chronic care management and care coordination services leading the way. These services are essential for improving patient outcomes and reducing healthcare costs. The technology segment, including data analytics and telehealth solutions, follows closely, reflecting the integration of digital tools to enhance healthcare delivery. Population health management is gaining significant traction, as it enables providers to manage patient populations more effectively. The demand for patient engagement solutions is rising, driven by the need for improved patient-provider communication and adherence to treatment plans. Preventive care services are emerging as a key focus area, emphasizing early intervention and health promotion. The market is further propelled by advancements in healthcare IT infrastructure and increased emphasis on value-based care initiatives, creating lucrative opportunities for stakeholders.

Market Segmentation
TypeIntegrated Care Models, Accountable Care Organizations, Patient-Centered Medical Homes, Pay-for-Performance, Bundled Payments
ProductSoftware Solutions, Analytics Solutions, Consulting Services
ServicesCare Management Services, Patient Engagement Solutions, Risk Management Services
TechnologyTelemedicine, Electronic Health Records, Remote Monitoring, Mobile Health Applications
ComponentHardware, Software, Services
ApplicationChronic Care Management, Population Health Management, Home Health Management
End UserHealthcare Providers, Payers, Patients
DeploymentOn-Premise, Cloud-Based, Hybrid
FunctionalityData Analytics, Interoperability, Patient Engagement

The Value-Based Healthcare Services Market is witnessing a dynamic shift in market share and pricing strategies, driven by innovation and strategic collaborations. New product launches are reshaping the landscape, with healthcare providers focusing on patient-centric solutions. This transformation is fueled by the integration of advanced technologies, which enhance patient outcomes and optimize operational efficiencies. The market is characterized by a competitive pricing environment, encouraging providers to innovate and differentiate their offerings. Competition in the Value-Based Healthcare Services Market is intensifying, with key players benchmarking against industry leaders to maintain their competitive edge. Regulatory influences are significant, as government policies and reimbursement models are pivotal in shaping market dynamics. North America leads in regulatory advancements, fostering a conducive environment for growth. The market is poised for expansion, with emerging economies investing heavily in healthcare infrastructure, thus providing lucrative opportunities for stakeholders. Challenges such as compliance and data security persist, yet technological advancements promise substantial growth potential.

Tariff Impact:

The Value-Based Healthcare Services Market is intricately influenced by global tariffs, geopolitical tensions, and evolving supply chain dynamics. In Japan and South Korea, the focus is on enhancing healthcare technology and infrastructure, driven by tariff-induced cost pressures and the need for self-reliance in medical supplies. China is accelerating the development of domestic healthcare innovations, navigating export restrictions and fostering collaborations to mitigate geopolitical risks. Taiwan, with its robust healthcare technology sector, remains vulnerable to regional tensions but continues to be a pivotal player. Globally, the parent market is growing steadily, with a shift towards integrated care models. By 2035, the market is expected to thrive on strategic partnerships and technological advancements, although Middle East conflicts may disrupt global supply chains and elevate energy prices, influencing operational costs.

Geographical Overview:

The value-based healthcare services market is witnessing notable expansion across diverse regions, each exhibiting unique growth catalysts. North America remains at the forefront, propelled by a shift towards patient-centric care models and substantial investments in healthcare IT infrastructure. The region's focus on improving patient outcomes and reducing costs further accelerates market growth. Europe follows, driven by government initiatives promoting value-based care and strong regulatory frameworks that encourage innovation. Asia Pacific is experiencing rapid growth, buoyed by increasing healthcare expenditures and a burgeoning middle class seeking quality healthcare solutions. Countries like China and India are emerging as key players, with significant investments in healthcare technology and infrastructure. Latin America and the Middle East & Africa are also gaining traction. In Latin America, countries such as Brazil and Mexico are adopting value-based care models to enhance healthcare efficiency. Meanwhile, the Middle East & Africa are recognizing the potential of such models to improve healthcare delivery and patient outcomes.

Key Trends and Drivers:

The Value-Based Healthcare Services Market is experiencing robust growth, propelled by the increasing emphasis on patient-centric care and cost-effectiveness. A key trend is the integration of digital health technologies, which enhance patient engagement and streamline care coordination. Telehealth services and remote monitoring are becoming more prevalent, providing patients with convenient access to healthcare services while reducing costs. Another significant driver is the shift towards outcome-based reimbursement models, incentivizing healthcare providers to improve patient outcomes. This shift encourages the adoption of preventive care and chronic disease management programs. Additionally, the growing prevalence of chronic diseases and an aging population are further fueling demand for value-based healthcare solutions. Healthcare systems are increasingly focused on improving quality while managing costs effectively. Opportunities are abundant in developing economies where healthcare infrastructure is evolving. Companies that offer scalable, technology-driven solutions are well-positioned to capitalize on these emerging markets. Furthermore, collaborations between healthcare providers, payers, and technology companies are fostering innovation and expanding access to value-based care. As the industry continues to evolve, the focus on personalized care and data-driven decision-making will drive sustained growth in the market.

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Services
  • 2.4 Key Market Highlights by Technology
  • 2.5 Key Market Highlights by Component
  • 2.6 Key Market Highlights by Application
  • 2.7 Key Market Highlights by End User
  • 2.8 Key Market Highlights by Deployment
  • 2.9 Key Market Highlights by Functionality

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Integrated Care Models
    • 4.1.2 Accountable Care Organizations
    • 4.1.3 Patient-Centered Medical Homes
    • 4.1.4 Pay-for-Performance
    • 4.1.5 Bundled Payments
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Software Solutions
    • 4.2.2 Analytics Solutions
    • 4.2.3 Consulting Services
  • 4.3 Market Size & Forecast by Services (2020-2035)
    • 4.3.1 Care Management Services
    • 4.3.2 Patient Engagement Solutions
    • 4.3.3 Risk Management Services
  • 4.4 Market Size & Forecast by Technology (2020-2035)
    • 4.4.1 Telemedicine
    • 4.4.2 Electronic Health Records
    • 4.4.3 Remote Monitoring
    • 4.4.4 Mobile Health Applications
  • 4.5 Market Size & Forecast by Component (2020-2035)
    • 4.5.1 Hardware
    • 4.5.2 Software
    • 4.5.3 Services
  • 4.6 Market Size & Forecast by Application (2020-2035)
    • 4.6.1 Chronic Care Management
    • 4.6.2 Population Health Management
    • 4.6.3 Home Health Management
  • 4.7 Market Size & Forecast by End User (2020-2035)
    • 4.7.1 Healthcare Providers
    • 4.7.2 Payers
    • 4.7.3 Patients
  • 4.8 Market Size & Forecast by Deployment (2020-2035)
    • 4.8.1 On-Premise
    • 4.8.2 Cloud-Based
    • 4.8.3 Hybrid
  • 4.9 Market Size & Forecast by Functionality (2020-2035)
    • 4.9.1 Data Analytics
    • 4.9.2 Interoperability
    • 4.9.3 Patient Engagement

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Services
      • 5.2.1.4 Technology
      • 5.2.1.5 Component
      • 5.2.1.6 Application
      • 5.2.1.7 End User
      • 5.2.1.8 Deployment
      • 5.2.1.9 Functionality
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Services
      • 5.2.2.4 Technology
      • 5.2.2.5 Component
      • 5.2.2.6 Application
      • 5.2.2.7 End User
      • 5.2.2.8 Deployment
      • 5.2.2.9 Functionality
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Services
      • 5.2.3.4 Technology
      • 5.2.3.5 Component
      • 5.2.3.6 Application
      • 5.2.3.7 End User
      • 5.2.3.8 Deployment
      • 5.2.3.9 Functionality
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Services
      • 5.3.1.4 Technology
      • 5.3.1.5 Component
      • 5.3.1.6 Application
      • 5.3.1.7 End User
      • 5.3.1.8 Deployment
      • 5.3.1.9 Functionality
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Services
      • 5.3.2.4 Technology
      • 5.3.2.5 Component
      • 5.3.2.6 Application
      • 5.3.2.7 End User
      • 5.3.2.8 Deployment
      • 5.3.2.9 Functionality
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Services
      • 5.3.3.4 Technology
      • 5.3.3.5 Component
      • 5.3.3.6 Application
      • 5.3.3.7 End User
      • 5.3.3.8 Deployment
      • 5.3.3.9 Functionality
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Services
      • 5.4.1.4 Technology
      • 5.4.1.5 Component
      • 5.4.1.6 Application
      • 5.4.1.7 End User
      • 5.4.1.8 Deployment
      • 5.4.1.9 Functionality
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Services
      • 5.4.2.4 Technology
      • 5.4.2.5 Component
      • 5.4.2.6 Application
      • 5.4.2.7 End User
      • 5.4.2.8 Deployment
      • 5.4.2.9 Functionality
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Services
      • 5.4.3.4 Technology
      • 5.4.3.5 Component
      • 5.4.3.6 Application
      • 5.4.3.7 End User
      • 5.4.3.8 Deployment
      • 5.4.3.9 Functionality
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Services
      • 5.4.4.4 Technology
      • 5.4.4.5 Component
      • 5.4.4.6 Application
      • 5.4.4.7 End User
      • 5.4.4.8 Deployment
      • 5.4.4.9 Functionality
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Services
      • 5.4.5.4 Technology
      • 5.4.5.5 Component
      • 5.4.5.6 Application
      • 5.4.5.7 End User
      • 5.4.5.8 Deployment
      • 5.4.5.9 Functionality
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Services
      • 5.4.6.4 Technology
      • 5.4.6.5 Component
      • 5.4.6.6 Application
      • 5.4.6.7 End User
      • 5.4.6.8 Deployment
      • 5.4.6.9 Functionality
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Services
      • 5.4.7.4 Technology
      • 5.4.7.5 Component
      • 5.4.7.6 Application
      • 5.4.7.7 End User
      • 5.4.7.8 Deployment
      • 5.4.7.9 Functionality
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Services
      • 5.5.1.4 Technology
      • 5.5.1.5 Component
      • 5.5.1.6 Application
      • 5.5.1.7 End User
      • 5.5.1.8 Deployment
      • 5.5.1.9 Functionality
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Services
      • 5.5.2.4 Technology
      • 5.5.2.5 Component
      • 5.5.2.6 Application
      • 5.5.2.7 End User
      • 5.5.2.8 Deployment
      • 5.5.2.9 Functionality
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Services
      • 5.5.3.4 Technology
      • 5.5.3.5 Component
      • 5.5.3.6 Application
      • 5.5.3.7 End User
      • 5.5.3.8 Deployment
      • 5.5.3.9 Functionality
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Services
      • 5.5.4.4 Technology
      • 5.5.4.5 Component
      • 5.5.4.6 Application
      • 5.5.4.7 End User
      • 5.5.4.8 Deployment
      • 5.5.4.9 Functionality
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Services
      • 5.5.5.4 Technology
      • 5.5.5.5 Component
      • 5.5.5.6 Application
      • 5.5.5.7 End User
      • 5.5.5.8 Deployment
      • 5.5.5.9 Functionality
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Services
      • 5.5.6.4 Technology
      • 5.5.6.5 Component
      • 5.5.6.6 Application
      • 5.5.6.7 End User
      • 5.5.6.8 Deployment
      • 5.5.6.9 Functionality
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Services
      • 5.6.1.4 Technology
      • 5.6.1.5 Component
      • 5.6.1.6 Application
      • 5.6.1.7 End User
      • 5.6.1.8 Deployment
      • 5.6.1.9 Functionality
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Services
      • 5.6.2.4 Technology
      • 5.6.2.5 Component
      • 5.6.2.6 Application
      • 5.6.2.7 End User
      • 5.6.2.8 Deployment
      • 5.6.2.9 Functionality
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Services
      • 5.6.3.4 Technology
      • 5.6.3.5 Component
      • 5.6.3.6 Application
      • 5.6.3.7 End User
      • 5.6.3.8 Deployment
      • 5.6.3.9 Functionality
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Services
      • 5.6.4.4 Technology
      • 5.6.4.5 Component
      • 5.6.4.6 Application
      • 5.6.4.7 End User
      • 5.6.4.8 Deployment
      • 5.6.4.9 Functionality
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Services
      • 5.6.5.4 Technology
      • 5.6.5.5 Component
      • 5.6.5.6 Application
      • 5.6.5.7 End User
      • 5.6.5.8 Deployment
      • 5.6.5.9 Functionality

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 Evolent Health
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Privia Health
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Oak Street Health
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 Agilon Health
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 Village MD
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 Lumeris
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 Health Catalyst
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Innovaccer
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Signify Health
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 Care Centrix
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 Aledade
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 Clover Health
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 Bright Health
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 Cityblock Health
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Somatus
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 Iora Health
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 Chen Med
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 Landmark Health
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 One Medical
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis
  • 8.20 Alignment Healthcare
    • 8.20.1 Overview
    • 8.20.2 Product Summary
    • 8.20.3 Financial Performance
    • 8.20.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제